AMAG Pharmaceuticals Inc

Historical 13F Holders

Symbol
AMAG
CUSIP
00163U106
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1 1.00 $14.00
2024 Q4 1 1.00 $14.00
2024 Q3 1 1.00 $14.00
2024 Q2 1 1.00 $14.00
2024 Q1 1 1.00 $14.00
2023 Q4 1 1.00 $14.00
2023 Q3 1 1.00 $14.00
2023 Q2 1 1.00 $14.00
2023 Q1 1 1.00 $14.00
2022 Q4 1 1.00 $14.00
2022 Q3 1 1.00 $0
2022 Q2 1 1.00 $0
2022 Q1 1 1.00 $0
2021 Q4 1 1.00 $0
2021 Q3 1 1.00 $0
2021 Q2 1 1.00 $0
2021 Q1 1 1.00 $0
2020 Q4 1 1.00 $0
2020 Q3 126 41.5 M $390 M
2020 Q2 132 38.6 M $295 M
2020 Q1 132 39.7 M $245 M
2019 Q4 149 42.4 M $516 M
2019 Q3 178 40.2 M $464 M
2019 Q2 199 41.4 M $413 M
2019 Q1 180 40.8 M $526 M
2018 Q4 206 45.0 M $686 M
2018 Q3 208 47.0 M $941 M
2018 Q2 187 47.2 M $921 M
2018 Q1 184 40.1 M $808 M
2017 Q4 179 40.5 M $537 M
2017 Q3 203 42.1 M $774 M
2017 Q2 190 43.6 M $802 M
2017 Q1 200 41.7 M $940 M
2016 Q4 219 42.1 M $1.47 B
2016 Q3 196 41.3 M $1.01 B
2016 Q2 180 43.3 M $1.03 B
2016 Q1 193 43.2 M $1.01 B
2015 Q4 188 44.4 M $1.34 B
2015 Q3 218 46.7 M $1.86 B
2015 Q2 215 38.8 M $2.68 B
2015 Q1 200 39.9 M $2.18 B
2014 Q4 158 32.0 M $1.36 B
2014 Q3 122 26.6 M $848 M
2014 Q2 111 27.2 M $563 M
2014 Q1 110 26.3 M $508 M